Vortioxetine (Lu AA21004) HBr

CAS No. 960203-27-4

Vortioxetine (Lu AA21004) HBr ( —— )

Catalog No. M16850 CAS No. 960203-27-4

Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 39 In Stock
25MG 52 In Stock
50MG 80 In Stock
100MG 113 In Stock
200MG 177 In Stock
500MG 332 In Stock
1G 478 In Stock

Biological Information

  • Product Name
    Vortioxetine (Lu AA21004) HBr
  • Note
    Research use only, not for human use.
  • Brief Description
    Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT.
  • Description
    Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT1A; 5-HT1B; 5-HT3A; 5-HT7; SERT
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    960203-27-4
  • Formula Weight
    379.36
  • Molecular Formula
    C18H22N2S·HBr
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 17 mg/mL (44.81 mM); DMSO: 76 mg/mL (200.33 mM)
  • SMILES
    CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bang-Andersen B, et al. J Med Chem, 2011, 54(9), 3206-322
molnova catalog
related products
  • NAN-190 hydrobromide

    NAN-190 is a 5-HT1A receptor antagonist with Ki of 0.6 nM; also potently blocks the α2-adrenergic receptor.

  • GR 46611

    GR 46611 is a selective 5-HT1B and 5-HT1D receptor agonist and can be used in studies about the treatment of epilepsy.

  • Setiptiline maleate

    A tetracyclic antidepressant (TeCA) that acts as a norepinephrine reuptake inhibitor, α2-adrenergic receptor antagonist, and serotonin receptor antagonist.